HKSE - Delayed Quote HKD
HighTide Therapeutics, Inc. (2511.HK)
1.670
+0.030
+(1.83%)
At close: April 23 at 4:08:49 PM GMT+8
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Liu (Liping Ph.D.) Chief Executive Officer | Conversion | Apr 1, 2025 | 88,457,872 |
| Ma (Lixiong) Director (Non-Executive) | Conversion | Apr 1, 2025 | 29,899,344 |
| Yu (Meng) Director (Executive) | Conversion | Apr 1, 2025 | 3,256,830 |
| Zhu (Xun) Director (Non-Executive) | Conversion | Apr 1, 2025 | 1,190,832 |
Related Tickers
2137.HK Brii Biosciences Limited
1.820
-0.55%
6628.HK Transcenta Holding Limited
1.270
+4.10%
9606.HK Duality Biotherapeutics, Inc.
218.600
-0.46%
INTS Intensity Therapeutics, Inc.
1.3000
-28.18%
APLM Apollomics, Inc.
6.19
+7.47%
CGEM Cullinan Therapeutics, Inc.
8.38
+0.12%
KALV KalVista Pharmaceuticals, Inc.
12.45
+1.22%
VRDN Viridian Therapeutics, Inc.
13.51
-1.82%
APM Aptorum Group Limited
0.9601
+6.80%
ELEV Elevation Oncology, Inc.
0.3788
+1.83%